These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19800911)

  • 21. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
    Colpaert FC; Tarayre JP; Koek W; Pauwels PJ; Bardin L; Xu XJ; Wiesenfeld-Hallin Z; Cosi C; Carilla-Durand E; Assié MB; Vacher B
    Neuropharmacology; 2002 Nov; 43(6):945-58. PubMed ID: 12423664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine.
    Boules M; Johnston H; Tozy J; Smith K; Li Z; Richelson E
    Behav Pharmacol; 2011 Sep; 22(5-6):573-81. PubMed ID: 21691202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective potentiation of gabapentin-mediated antinociception in the rat formalin test by the nicotinic acetylcholine receptor agonist ABT-594.
    Munro G; Dyhr H; Grunnet M
    Neuropharmacology; 2010 Sep; 59(3):208-17. PubMed ID: 20562022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent bullatine A enhances morphine antinociception and inhibits morphine antinociceptive tolerance by indirect activation of spinal κ-opioid receptors.
    Huang Q; Sun ML; Chen Y; Li XY; Wang YX
    J Ethnopharmacol; 2017 Jan; 196():151-159. PubMed ID: 27989510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptors.
    Zhang J; Xiao YD; Jordan KG; Hammond PS; Van Dyke KM; Mazurov AA; Speake JD; Lippiello PM; James JW; Letchworth SR; Bencherif M; Hauser TA
    Eur J Pharm Sci; 2012 Dec; 47(5):813-23. PubMed ID: 23036283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential analgesic sensitivity of two distinct neuropathic pain models.
    Decosterd I; Allchorne A; Woolf CJ
    Anesth Analg; 2004 Aug; 99(2):457-63, table of contents. PubMed ID: 15271725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal gabapentin enhances the analgesic effects of subtherapeutic dose morphine in a rat experimental pancreatitis model.
    Smiley MM; Lu Y; Vera-Portocarrero LP; Zidan A; Westlund KN
    Anesthesiology; 2004 Sep; 101(3):759-65. PubMed ID: 15329602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties.
    Tzschentke TM; Christoph T; Kögel B; Schiene K; Hennies HH; Englberger W; Haurand M; Jahnel U; Cremers TI; Friderichs E; De Vry J
    J Pharmacol Exp Ther; 2007 Oct; 323(1):265-76. PubMed ID: 17656655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
    Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
    J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the antinociceptive profiles of morphine and oxycodone in two models of inflammatory and osteoarthritic pain in rat.
    Garcia MM; Goicoechea C; Avellanal M; Traseira S; Martín MI; Sánchez-Robles EM
    Eur J Pharmacol; 2019 Jul; 854():109-118. PubMed ID: 30978319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.
    Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L
    Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse.
    Suh HW; Song DK; Choi SR; Chung KM; Kim YH
    Neuropeptides; 1996 Oct; 30(5):479-84. PubMed ID: 8923511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-addictive orally-active kappa opioid agonists for the treatment of peripheral pain in rats.
    Beck TC; Reichel CM; Helke KL; Bhadsavle SS; Dix TA
    Eur J Pharmacol; 2019 Aug; 856():172396. PubMed ID: 31103632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
    Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
    Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans.
    Persson J; Hasselström J; Wiklund B; Heller A; Svensson JO; Gustafsson LL
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):750-8. PubMed ID: 9698948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesic Effects of the GIRK Activator, VU0466551, Alone and in Combination with Morphine in Acute and Persistent Pain Models.
    Abney KK; Bubser M; Du Y; Kozek KA; Bridges TM; Linsdley CW; Daniels JS; Morrison RD; Wickman K; Hopkins CR; Jones CK; Weaver CD
    ACS Chem Neurosci; 2019 Mar; 10(3):1294-1299. PubMed ID: 30474955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gabapentin enhances the analgesic effect of morphine in healthy volunteers.
    Eckhardt K; Ammon S; Hofmann U; Riebe A; Gugeler N; Mikus G
    Anesth Analg; 2000 Jul; 91(1):185-91. PubMed ID: 10866910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nornicotine is self-administered intravenously by rats.
    Bardo MT; Green TA; Crooks PA; Dwoskin LP
    Psychopharmacology (Berl); 1999 Oct; 146(3):290-6. PubMed ID: 10541729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.